MedTrace Logo

Maximal Strength Training in High-level Female Football Players

NCT04048928 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2019-08-28

No results posted yet for this study

Summary

Introduction: Maximal strength increments are reported to result in improvements in sprint speed and jump height in elite male football players. Although similar effects are expected in females, this is yet to be elucidated. The aim of this study was to examine the effect of maximal strength training on sprint speed and jump height in high-level female football players.

Methods: Two female football teams were team-cluster-randomized to a training group (TG) performing maximal strength training (MST) twice a week for five weeks, or control group (CG) doing their regular pre-season preparations. The MST consisted of 3-4 sets of 4-6 repetitions at ≥85% of 1 repetition maximum (1RM) in a squat exercise. Sprint speed and jump height were assessed in 5-, 10- and 15 meter sprints and a counter-movement jump (CMJ) test, respectively. 19 participants in TG (18.3 ± 2.7 years) and 14 in CG (18.3 ± 2.4 years) completed pre- and posttests and were carried forward for final analyses.

Conditions

  • Strength Training
  • Soccer

Interventions

BEHAVIORAL

maximal strength training

The training group (TG) performed MST training carried out as free-barbell squats twice a week over five weeks.

Sponsors & Collaborators

  • University of Tromso

    lead OTHER

Principal Investigators

  • Sigurd pedersen, MSc · UiT, TheArctic University of Norway

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-10
Primary Completion
2018-04-11
Completion
2018-04-11

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04048928 on ClinicalTrials.gov